GB0801674D0 - Compounds having CRTH2 antagonist activity - Google Patents
Compounds having CRTH2 antagonist activityInfo
- Publication number
- GB0801674D0 GB0801674D0 GBGB0801674.3A GB0801674A GB0801674D0 GB 0801674 D0 GB0801674 D0 GB 0801674D0 GB 0801674 A GB0801674 A GB 0801674A GB 0801674 D0 GB0801674 D0 GB 0801674D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- antagonist activity
- crth2 antagonist
- crth2
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940124003 CRTH2 antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0801674A GB2457040A (en) | 2008-01-30 | 2008-01-30 | 1-Acetic acid indole derivatives with PGD2 activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0801674A GB2457040A (en) | 2008-01-30 | 2008-01-30 | 1-Acetic acid indole derivatives with PGD2 activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB0801674D0 true GB0801674D0 (en) | 2008-03-05 |
| GB2457040A GB2457040A (en) | 2009-08-05 |
Family
ID=39186569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0801674A Pending GB2457040A (en) | 2008-01-30 | 2008-01-30 | 1-Acetic acid indole derivatives with PGD2 activity |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2457040A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
| WO2014026959A1 (en) * | 2012-08-13 | 2014-02-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for treatment of cystic fibrosis |
| CN103588697B (en) * | 2012-08-14 | 2017-09-15 | 中国科学院上海药物研究所 | Disubstituted benzenes sulfamide compound of one class 2,5 and its production and use |
| JP7763510B2 (en) * | 2021-09-03 | 2025-11-04 | 深▲セン▼零一生命科技有限責任公司 | Indole compounds, their preparation and use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3557142A (en) * | 1968-02-20 | 1971-01-19 | Sterling Drug Inc | 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters |
| KR100584650B1 (en) * | 1998-03-31 | 2006-05-30 | 디 인스티튜트스 포 파마슈티컬 디스커버리, 엘엘씨 | Substituted indolalkanoic acids |
| EP2046740B1 (en) * | 2006-07-22 | 2012-05-23 | Oxagen Limited | Compounds having crth2 antagonist activity |
-
2008
- 2008-01-30 GB GB0801674A patent/GB2457040A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB2457040A (en) | 2009-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL206959A0 (en) | Compounds having crth2 antagonist activity | |
| IL196640A0 (en) | Compounds having crth2 antagonist activity | |
| ZA200807913B (en) | Salts with CRTH2 antagonist activity | |
| GB0722216D0 (en) | Use of crth2 antagonist compounds | |
| GB0722203D0 (en) | Use of CRTH2 antagonist compounds | |
| GB0810902D0 (en) | New compounds | |
| GB0807862D0 (en) | Compounds | |
| EP2518041A4 (en) | Benzyl compound | |
| IL210344A0 (en) | New compounds | |
| ZA201104777B (en) | Substituted quinazoline compounds | |
| ZA200900393B (en) | Compounds having CRTH2 antagonist activity | |
| GB0800367D0 (en) | Compounds | |
| GB0801674D0 (en) | Compounds having CRTH2 antagonist activity | |
| ZA201101390B (en) | Self cleaning arrangement | |
| HU0800478D0 (en) | New compounds | |
| GB0818365D0 (en) | Quinoline compounds | |
| GB0801220D0 (en) | Compounds | |
| GB0801132D0 (en) | Compounds having CRTH2 antagonist activity | |
| GB0801671D0 (en) | Compounds having crth2 antagonist activity | |
| GB0820526D0 (en) | Compounds having crth2 antagonist activity | |
| GB0800874D0 (en) | Compounds having CRTH2 antagonist activity | |
| GB0801672D0 (en) | Compounds having crth2 antagonist activity | |
| GB0801131D0 (en) | Compounds having CRTH2 antagonist activity | |
| EP2463292A4 (en) | Compound having neurite-outgrowing activity | |
| HK1148522A (en) | Compounds having crth2 antagonist activity |